Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Amygdala Neurosciences, Inc. (a private company) is developing pharmacotherapies to address the growing unmet need associated with substance use...
Amygdala Neurosciences (a private company) has been awarded up to $1.35 million NIH grant support for the project titled "26- & 39-Week Toxicity...
Amygdala Neurosciences (a private company) announced today the start of dosing in a NIH/NIAID Phase 1b study to test the safety of ANS-6637, and how...
Amygdala Neurosciences (a private company) announced today the SEARCH program of Phase 2 clinical studies which are sponsored by the National...
Amygdala Neurosciences (a private company) announced today that the National Institute on Alcohol Abuse and Alcoholism (NIAAA, a division of NIH)...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.